BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 5294305)

  • 1. A further study on measles vaccination in Nigerian children.
    Hendrickse RG; Montefiore D; Sherman PM; Sofoluwe GO
    Bull World Health Organ; 1965; 32(6):803-8. PubMed ID: 5294305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WHO-supported comparative studies of attenuated live measles virus vaccines.
    Cockburn WC; Pecenka J; Sundaresan T
    Bull World Health Organ; 1966; 34(2):223-31. PubMed ID: 4161187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative studies of measles vaccines in a controlled trial in the USSR.
    Bolotovskij VM; Nefedova LA; Gelikman BG; Zargaryants AT; Zetilova LP; Nastasina KT
    Bull World Health Organ; 1966; 34(6):859-64. PubMed ID: 5296534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative trial of live measles vaccines in Czechoslovakia.
    Syrůcek L; Helcl J; Sejda J; Svandová E; Staninec M; Grantová H; Mertenová J; Mílek E; Mirovský J; Procházka J; Strauss J; Zdrazílek J
    Bull World Health Organ; 1965; 32(6):779-89. PubMed ID: 5294303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on attenuated measles-virus vaccines in Canada.
    Nagler FP; Foley AR; Furesz J; Martineau G
    Bull World Health Organ; 1965; 32(6):791-801. PubMed ID: 5294304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization of six-month-old infants with different doses of Edmonston-Zagreb and Schwarz measles vaccines.
    Markowitz LE; Sepulveda J; Diaz-Ortega JL; Valdespino JL; Albrecht P; Zell ER; Stewart J; Zarate ML; Bernier RH
    N Engl J Med; 1990 Mar; 322(9):580-7. PubMed ID: 2304505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of the reaction-causing properties and the immunological and epidemiological effectiveness of Leningrad-16 and Schwarz live measles vaccines.
    Bolotovskij VM; Zetilova LP
    Bull World Health Organ; 1968; 39(2):293-8. PubMed ID: 4881072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy of three measles vaccines in Indian children.
    Banerjee K; Shaikh N; Phadke M; Bedekar SS; Rauta SK; Mehta JM
    Indian J Public Health; 1998; 42(4):113-9. PubMed ID: 10389523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aerosolized measles and measles-rubella vaccines induce better measles antibody booster responses than injected vaccines: randomized trials in Mexican schoolchildren.
    Bennett JV; Fernandez de Castro J; Valdespino-Gomez JL; Garcia-Garcia Mde L; Islas-Romero R; Echaniz-Aviles G; Jimenez-Corona A; Sepulveda-Amor J
    Bull World Health Organ; 2002; 80(10):806-12. PubMed ID: 12471401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trial of a reduced dose of measles vaccine in Nigerian children.
    Wallace RB; Landrigan PJ; Smith EA; Pifer J; Teller B; Foster SO
    Bull World Health Organ; 1976; 53(4):361-4. PubMed ID: 1086728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative serological efficacy of the measles vaccine strains Edmonston-Zagreb, Schwarz and AIK-C in Togolese infants of 4-5 months and 8-10 months].
    Tidjani O; Grunitzky B; Guérin N; Lévy-Bruhl D; Lecam N; Xuereff C; Tatagan K
    Bull Soc Pathol Exot; 1991; 84(5 Pt 5):873-84. PubMed ID: 1819435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of antibody after administration of monovalent and combined live attenuated measles, mumps, and rubella virus vaccines.
    Weibel RE; Buynak EB; McLean AA; Hilleman MR
    Pediatrics; 1978 Jan; 61(1):5-11. PubMed ID: 263873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled epidemiological study of live measles vaccines in Poland.
    Polish Measles Vaccination Committee
    Bull World Health Organ; 1971; 45(3):331-5. PubMed ID: 5316912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low seroconversion rates to measles vaccine among children in Nigeria.
    Adu FD; Akinwolere OA; Tomori O; Uche LN
    Bull World Health Organ; 1992; 70(4):457-60. PubMed ID: 1394778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Field trial of combined yellow fever and measles vaccines among children in Nigeria.
    Adu FD; Omotade OO; Oyedele OI; Ikusika O; Odemuyiwa SO; Onoja AL
    East Afr Med J; 1996 Sep; 73(9):579-82. PubMed ID: 8991237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measles HI-antibody levels in Lagos children, Nigeria: a follow-up study to resurgence of measles in Lagos metropolis.
    Oyefolu AO; Omilabu SA
    West Afr J Med; 2001; 20(3):238-42. PubMed ID: 11922159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study and evaluation of further attenuated, live measles vaccines alone and in combination with mumps and rubella vaccines.
    Wegmann A; Glück R; Just M; Mischler R; Paroz P; Germanier R
    Dev Biol Stand; 1986; 65():69-74. PubMed ID: 3556778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of efficacy of the standard potency Edmonston-Zagreb live, attenuated measles vaccine in African infants.
    Kiepiela P; Coovadia HM; Loening WE; Coward P; Botha G; Hugo J; Becker PJ
    Bull World Health Organ; 1991; 69(2):221-7. PubMed ID: 1860150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.
    Nolan T; Bernstein DI; Block SL; Hilty M; Keyserling HL; Marchant C; Marshall H; Richmond P; Yogev R; Cordova J; Cho I; Mendelman PM;
    Pediatrics; 2008 Mar; 121(3):508-16. PubMed ID: 18310199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measles control in Maputo, Mozambique, using a single dose of Schwarz vaccine at age 9 months.
    Cutts FT; Monteiro O; Tabard P; Cliff J
    Bull World Health Organ; 1994; 72(2):227-31. PubMed ID: 8205642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.